Neurology · Indianapolis area, IN
Neurology studies in Indianapolis area, IN
28 recruiting studies have a site in the Indianapolis area. This page includes nearby cities such as Carmel, Fishers, Greenwood, Avon.
28 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- Indianapolis, IN + 35 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Diagnosing Epilepsy To EffeCT Change
Epiminder America, Inc.
- Location
- Indianapolis, IN + 21 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Regeneron Pharmaceuticals
- Location
- Indianapolis, IN + 41 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Zenas BioPharma (USA), LLC
- Location
- Indianapolis, IN + 24 other US sites
- Eligibility basics
- Ages 18–60
- RecruitingPhase 1
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD
Alnylam Pharmaceuticals
- Location
- Indianapolis, IN
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Alpha Cognition, Inc
- Location
- Fort Wayne, IN + 21 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
Regeneron Pharmaceuticals
- Location
- Indianapolis, IN + 42 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine
Pfizer
- Location
- Indianapolis, IN + 15 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)
Alnylam Pharmaceuticals
- Location
- Indianapolis, IN + 3 other US sites
- Eligibility basics
- Ages 40–55
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Dianthus Therapeutics
- Location
- Indianapolis, IN + 29 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Bristol-Myers Squibb
- Location
- Indianapolis, IN + 22 other US sites
- Eligibility basics
- Ages 60–85
- RecruitingPhase 2
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Eli Lilly and Company
- Location
- Indianapolis, IN + 29 other US sites
- Eligibility basics
- Ages 55–85
- RecruitingPhase 2
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Appello Pharmaceuticals, Inc.
- Location
- Indianapolis, IN + 29 other US sites
- Eligibility basics
- Ages 30–80
- RecruitingPhase 3
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Novartis Pharmaceuticals
- Location
- Indianapolis, IN + 39 other US sites
- Eligibility basics
- Ages 21–70
- RecruitingPhase 2/Phase 3
A Study of Buntanetap in Participants With PD
Annovis Bio Inc.
- Location
- Indianapolis, IN + 26 other US sites
- Eligibility basics
- Ages 40–85
- RecruitingPhase 2/Phase 3
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Exciva GmbH
- Location
- Indianapolis, IN + 6 other US sites
- Eligibility basics
- Ages 55–90
- RecruitingPhase 3
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Eli Lilly and Company
- Location
- Indianapolis, IN + 41 other US sites
- Eligibility basics
- Ages 55+
- RecruitingHealthy volunteers
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Mayo Clinic
- Location
- Indianapolis, IN + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Dominantly Inherited Alzheimer Network (DIAN)
Washington University School of Medicine
- Location
- Indianapolis, IN + 6 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 4
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Duke University
- Location
- Indianapolis, IN + 88 other US sites
- Eligibility basics
- Ages 75+
- RecruitingHealthy volunteers
ASSESS ALL ALS Study
St. Joseph's Hospital and Medical Center, Phoenix
- Location
- Indianapolis, IN + 35 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
PREVENT ALL ALS Study
St. Joseph's Hospital and Medical Center, Phoenix
- Location
- Indianapolis, IN + 30 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 2/Phase 3
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Washington University School of Medicine
- Location
- Indianapolis, IN + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 2/Phase 3
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Washington University School of Medicine
- Location
- Indianapolis, IN + 11 other US sites
- Eligibility basics
- Ages 18+
Who these studies look for
Most require a confirmed diagnosis; memory studies often ask for a study partner who knows you well to attend some visits.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.